Rui Avelar

Technik-/Wissenschafts-/F&E-Leiter bei EVOLUS, INC.

Vermögen: 4 Mio $ am 30.04.2024

62 Jahre

Health Technology

Consumer Services

Aktive Positionen von Rui Avelar

Unternehmen	Position	Beginn	Ende
EVOLUS, INC.	Technik-/Wissenschafts-/F&E-Leiter	01.01.2014	-

Unternehmen	Position	Beginn	Ende
AEON Biopharma Sub, Inc. AEON Biopharma Sub, Inc. Pharmaceuticals: OtherHealth Technology AEON Biopharma Sub, Inc. is a biopharmaceutical company. It focuses on developing a proprietary botulinum toxin complex, ABP-450, for debilitating medical conditions, with an initial focus on the neurology and gastroenterology markets. The company was founded by Robert E. Grant on February 24, 2012 and is headquartered in Newport Beach, CA.	Technik-/Wissenschafts-/F&E-Leiter	01.01.2014	01.02.2018
Allergan Medical Optics	Technik-/Wissenschafts-/F&E-Leiter	01.03.2011	01.12.2013

University of Toronto

Doctorate Degree

International

Vereinigte Staaten	4
Kanada	2

Operativ

Chief Tech/Sci/R&D Officer	3
Doctorate Degree	1

Sektoral

Health Technology	3
Consumer Services	2

Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Börsennotierte Unternehmen	1
EVOLUS, INC.	Health Technology

Private Unternehmen	2
AEON Biopharma Sub, Inc. AEON Biopharma Sub, Inc. Pharmaceuticals: OtherHealth Technology AEON Biopharma Sub, Inc. is a biopharmaceutical company. It focuses on developing a proprietary botulinum toxin complex, ABP-450, for debilitating medical conditions, with an initial focus on the neurology and gastroenterology markets. The company was founded by Robert E. Grant on February 24, 2012 and is headquartered in Newport Beach, CA.	Health Technology
Allergan Medical Optics

Private Unternehmen

Health Technology

Allergan Medical Optics